Shortening the ex vivo culture of CD19-specific CAR T-cells retains potent efficacy against acute lymphoblastic leukemia without CAR T-cell-related encephalopathy syndrome or severe cytokine release syndrome.
作者信息
Tu Sanfang, Huang Rui, Guo Zhenling, Deng Lan, Song Chaoyang, Zhou Xuan, Yue Chunyan, Zhang Lenghe, He Yanjie, Yang Jilong, Liang Zhao, Du Jingwen, Cao Peihua, Li Yushen, Chang Lung-Ji, Li Yuhua
机构信息
Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Department of Hepatobiliary Surgery II, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
出版信息
Am J Hematol. 2019 Dec;94(12):E322-E325. doi: 10.1002/ajh.25630. Epub 2019 Oct 2.
PMID:31489688
Abstract
摘要
Zotero 插件